Skip to content

13F-HR filed by a16z Capital Management, L.L.C.

a16z Capital Management, L.L.C. filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 11 holding rows worth $1,394,890,890.

Accession
0001540358-25-000007
Filed
2025-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 11 entries on the cover page, a total value of $1,394,890,890 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,394,890,890 with VALUE read as dollars as filed, 13F file number 028-23922. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
FIGMA INC CL A316841105COM16,246,129$842,686,711dollars as filed
META PLATFORMS INC CL A30303M102COM212,531$156,078,516dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,748,523$128,356,024dollars as filed
OMADA HEALTH INC68170A108COM4,614,574$102,028,231dollars as filed
BLOCK INC CL A852234103Stock1,016,697$73,476,692dollars as filed
MAZE THERAPEUTICS INC COM578784100Stock1,702,225$44,138,694dollars as filed
BIOAGE LABS INC COM09077V100Stock3,233,170$19,011,040dollars as filed
NAUTILUS BIOTECHNOLOGY INC63909J108COM17,653,917$14,915,794dollars as filed
CAMP4 THERAPEUTICS CORP13463J101COM2,125,339$6,376,017dollars as filed
ERASCA INC COM29479A108Stock2,862,500$6,240,250dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X209COMMON STOCK108,568$1,582,921dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001540358-25-000007this filing2025-11-14acceptance time not in the bulk data set